MULTI-INSTITUTIONAL ANALYSIS OF RISK FACTORS FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN MEN WITH PI-RADS 3 LESIONS

被引：0
作者：
Fang, Andrew
Shumaker, Luke
Khajir, Ghazal
Fan, Richard
Soodana-Prakash, Nachiketh
Patel, Hiten
Sprenkle, Preston
Sonn, Geoffrey
Punnen, Sanoj
Gupta, Gopal
Rais-Bahrami, Soroush
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP05-05
引用
收藏
页码：E78 / E78
页数：1
相关论文
共 50 条
  • [21] Variation in Clinically Significant Prostate Cancer on Fusion Biopsy of PI-RADS 3-5 Lesions Based on Ethnicity
    Edelblute, Beth
    Aly, Ahmed
    Jing, Zhe
    Wasaymahmood, Abdul
    Watts, Kara
    Sankin, Alex
    Maria, Pedro
    Guru, Khurshid
    Aboumohamed, Ahmed
    [J]. AMERICAN JOURNAL OF MENS HEALTH, 2025, 19 (01)
  • [22] EVALUATION OF PI-RADS VERSION 2.1 VS. 2.0 FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER IN BIOPSY-NAIVE MEN
    Mitchell, M. Huang
    Kathryn, E. Fink
    Li Eric, V.
    Mohammad, R. Siddiqui
    Nicole, Handa
    Ridwan, Alam
    Anugayarthi, Jawahar
    Edward, M. Schaeffer
    Ashley, E. Ross
    Hiten, D. Patel
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 75 - 76
  • [23] Perilesional Biopsies Increase Detection of Significant Prostate Cancer in Men with PI-RADS 4/5 Lesions: Validation of the PI-RADS Steering Committee Recommendation
    Lahoud, John
    Doan, Paul
    Kim, Lawrence
    Patel, Manish I.
    [J]. EUROPEAN UROLOGY, 2021, 80 (02) : 260 - 261
  • [24] Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer
    Tavakoli, Anoshirwan Andrej
    Hielscher, Thomas
    Badura, Patrick
    Goertz, Magdalena
    Kuder, Tristan Anselm
    Gnirs, Regula
    Schwab, Constantin
    Hohenfellner, Markus
    Schlemmer, Heinz-Peter
    Bonekamp, David
    [J]. RADIOLOGY, 2023, 306 (01) : 186 - 199
  • [25] Effects of the lesion size on clinically significant prostate cancer detection rates in PI-RADS category 3--5 lesions
    Ayranci, A.
    Caglar, U.
    Meric, A.
    Gelmis, M.
    Sarilar, O.
    Ozgor, F.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (07): : 526 - 531
  • [26] THE UTILITY OF PSA DENSITY IN PATIENTS WITH PI-RADS 3 LESIONS ACROSS A LARGE MULTI-INSTITUTIONAL COLLABORATIVE
    Drevik, Johnathan
    Dalimov, Zafardjan
    Syed, Kaynaat
    Danella, John
    Belkoff, Laurence
    Reese, Adam
    Tomaszewski, Jeffrey
    Trabulsi, Edouard
    Singer, Eric
    Jacobs, Bruce
    Raman, Jay
    Guzzo, Thomas
    Correa, Andres
    Smaldone, Marc
    Uzzo, Robert
    Ginzburg, Serge
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05) : E693 - E693
  • [27] Is PI-RADS 3/total lesion ratio associated with clinically-significant prostate cancer in patients with equivocal-risk lesions on multi-parametric MRI?
    Ghabili, Kamyar
    Swallow, Matthew
    Suarez-Sarmiento, Alfredo
    Syed, Jamil
    Leapman, Michael
    Weinreb, Jeffrey
    Sprenkle, Preston
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative
    Drevik, Johnathan
    Dalimov, Zafardjan
    Uzzo, Robert
    Danella, John
    Guzzo, Thomas
    Belkoff, Lawrence
    Raman, Jay
    Tomaszewski, Jeffrey
    Trabulsi, Edouard
    Reese, Adam
    Singer, Eric A.
    Syed, Kaynaat
    Jacobs, Bruce
    Correa, Andres
    Smaldone, Marc
    Ginzburg, Serge
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 490.e1 - 490.e6
  • [29] Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer
    Nayana U. Patel
    Kimberly E. Lind
    Kavita Garg
    David Crawford
    Priya N. Werahera
    Sajal S. Pokharel
    [J]. Abdominal Radiology, 2019, 44 : 705 - 712
  • [30] The use of 68Ga-PSMA PET/CT to stratify patients with PI-RADS 3 lesions according to clinically significant prostate cancer risk
    Yang, Jinhui
    Tang, Yongxiang
    Zhou, Chuanchi
    Zhou, Ming
    Li, Jian
    Hu, Shuo
    [J]. PROSTATE, 2023, 83 (05) : 430 - 439
12345